SpikImm has been founded by Truffle Capital and Institut Pasteur. SpikImm’s unique mission is to develop prophylactic mAbs against severe viral diseases in immunocompromised patients. First product is a potent anti-BK virus mAb to protect kidney transplant patients from severe complications caused by BKV, including nephropathies that may result in graft loss.
| Website | https://spikimm.com/ |
| Employees | 6 (1 on RocketReach) |
| Address | 53, Rue de Turbigo, Paris, Île-de-France 75003, FR |
| Industry | Biotechnology Research |
| Keywords | Monoclonal Antibodies, Therapeutic Antibodies, Viral Diseases, Immunology Research, Biotechnology, Immunotherapy, Antiviral Therapy, Pharmaceutical Research, Preventative Medicine, Drug Development, Viral Infection Treatment, Kidney Transplant, Transplant Patients |
| Competitors | Biogen, Novavax, Oncimmune, Ortho Clinical Diagnostics, VaxPro, LLC, Bio Health Solutions, Vaccine Consultancy BV, BIOSPHERE, Immunosolutions Inc, NextGen Immuno Therapeutics +1 more (view full list) |
Looking for a particular SpikImm employee's phone or email?
SpikImm Questions
1 people are employed at SpikImm.
SpikImm is based in Paris, Île-de-France.
Related Companies
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5
free lookups.
Search the #1
Contact Database
Get contact details of over 700M profiles across 60M
companies – all with industry-leading accuracy. Sales and Recruiter users, try out our
Email Finder Extension.
Use our
AI-Powered
Email Finder
Find business and personal emails and mobile phone numbers
with exclusive coverage across niche job titles, industries, and more
for unparalleled targeting. Also
available via our
Contact Data API.
G2Crowd Trusted
300K+
Plugin Users
